ProCE Banner Activity

Treatment-Refractory Advanced Urothelial Cancer: What to Do After Chemotherapy and/or Immunotherapy

Slideset Download
Download slides by Arjun Balar, MD on the role of antibody-drug conjugates in advanced urothelial cancer following chemotherapy and immunotherapy.

Released: May 04, 2021

Expiration: May 03, 2022

No longer available for credit.

Share

Faculty

Arjun Balar

Arjun Balar, MD

Associate Professor of Medicine
Perlmutter Cancer Center
NYU Langone Health
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Arjun Balar, MD

Associate Professor of Medicine
Perlmutter Cancer Center
NYU Langone Health
New York, New York